¡Ya estamos en ! Descubre más
27.38 USD
-0.38
1.37%
Al cierre Actualizado 16 oct, 4:00 p.m. EDT
Antes de la apertura del mercado
Después del cierre del mercado
27.38
0.00
0%
1 día
-1.37%
5 días
2.78%
1 mes
4.78%
3 meses
3.95%
6 meses
23.28%
En lo que va del año
28.6%
1 año
69.01%
5 años
4.54%
10 años
-58.26%
 

Acerca de: Pediatrix Medical Group Inc provides physician services to hospitals, intensive care units, and other medical units. The services provided by the company include maternal care for expectant mothers, intensive care for premature babies, cardiology care for infants suffering from heart defects, and anesthesia care during surgeries, among others. The company operates only under one segment which provides physician services including newborn, maternal-fetal, and other pediatric subspecialty care. It generates majority of the revenue through neonatology and other pediatric subspecialties.

Empleados: 2,260

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 78.6%
Neutral 21.4%
Negativo 0%
Positivo
Zacks Investment Research
hace 7 días
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-Term
Neutral
Business Wire
hace 16 días
HB Wealth Expands Into Texas With Experienced Three-Advisor Team
ATLANTA--(BUSINESS WIRE)--HB Wealth, one of the nation's largest independent, fee-only registered investment advisers, today announced that Steven D. Podnos, MD, MBA, CFP®, Rachel Podnos O'Leary, JD, CFP®, and Lauren Podnos-Garner, CFP®, have joined the firm. Together, the three advisors establish the firm's presence in Austin, Texas, with Rachel and Lauren based in Austin and Steven dividing his time between Austin and Cocoa Beach, Florida. The trio previously operated Wealth Care LLC, an inde.
HB Wealth Expands Into Texas With Experienced Three-Advisor Team
Positivo
Zacks Investment Research
hace 24 días
Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
MD posts 4% year-over-year revenue growth in the second quarter of 2026 despite lower patient volumes, aided by stronger reimbursement and acquisitions.
Can Pediatrix Sustain Growth Despite Lower Patient Volumes?
Positivo
Zacks Investment Research
el mes pasado
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term
Positivo
Zacks Investment Research
el mes pasado
Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?
Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?
Positivo
Zacks Investment Research
el mes pasado
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?
Positivo
Zacks Investment Research
el mes pasado
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock
Positivo
Zacks Investment Research
hace 2 meses
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.
Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio
Positivo
Zacks Investment Research
hace 2 meses
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock
Positivo
Zacks Investment Research
hace 2 meses
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.
Pediatrix Medical Tops Q2 Earnings on Better Cash Collections
Gráficos de precios implementados con Lightweight Charts™